Criminal Fear; Police Use Twitter, Too; Tearing Down Gandhi; Russin' War Crimes; Duterte Doesn't Need You; Nuclear. Activity. Again.; Great Balls of Fire; Growing Food in Space; North Star Moon Shot; and the AI's in the Details

Society

In Fear of Public Scrutiny, Chicago Officer Didn’t Use Gun While She Was Beaten ktla v

While wrestling on the ground, the the man allegedly grabbed the officer's head and slammed her face into the pavement repeatedly until she lost consciousness, [the superintendent] said.

Proxy War Status; Russia and Turkey's High Hopes; ISS For Sale; BLM Also Slanders Israel; and a Random, Unified Theory

War

Military Success in Syria Gives Putin Upper Hand in U.S. Proxy War nytimes v

For the first time since Afghanistan in the 1980s, the Russian military for the past year has been in direct combat with rebel forces trained and supplied by the C.I.A. The American-supplied Afghan fighters prevailed during that Cold War conflict. But this time the outcome — thus far — has been different.

Israel's Rise; Misunderstanding Shavuot; Unchaining Jewish Women; Blackmailing UN; UN's Ire(land); CA Chooses Death; Hidden in Sight in Petra; Flying Cars in Secret; Mobile Modular Phones; Internet on ISS; and Musk's Pentagon Visit

Israel

[OPINION, Caroline Glick] Israel rises in the East jpost

There was something poetic about the events that bookended the past week of diplomacy. This week began with French President François Hollande’s “peace” conference and ended with Prime Minister Benjamin Netanyahu’s state visit to Moscow.

Very well written reality check.

Liquid Biopsy; Stem Cell Walk; RNA Splicer; Butterfly Screens; Artificial Leaf; Transgendering Games; Banning Gas Cars in Norway; The Big Red Button; Space Station Tour; and Get Angry, Lose Work

Medical

A Blood Test for Cancer Gets Closer time

...new advances in genetic sequencing is leading to more hope for a liquid biopsy for cancer, a way to track cancer through the blood. In a study presented at the annual meeting of the American Society of Clinical Oncology, researchers from Guardant report encouraging results from a study involving 15,000 patients who were tested with the company’s test that looks at 70 different tumor genes. The technology picks up tiny fragments of DNA shed by tumors into the blood, and sequences the DNA to provide a picture of which mutations are present in the tumor. That helps doctors decide which treatments are most effective against that person’s cancer, since many of the newer anti-cancer drugs specifically target certain mutant processes common in cancer.